Fresenius Kabi iPSUM

German CDMO specializing in peptide API manufacturing. Dedicated peptide production building operating since 2024. Serves pharmaceutical industry with GMP manufacturing.

Fresenius Kabi iPSUM is listed as a CDMO in the peptide supply chain, serving Europe markets from Germany. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.